Wilmar International Limited (FRA:RTHA)

Intra-Cellular Therapies Revenue

In the year 2024, Wilmar International had annual revenue of $67.38B USD with 0.33% growth. Wilmar International had revenue of $36.44B in the half year ending December 31, 2024, a decrease of -2.20%.

• Revenue: $67.38B
• Revenue Growth: +0.33%
• P/S Ratio: 0.19
• Revenue / Employee: $673.79K
• Employees: 100,000
• Market Cap: 12.27B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	67.38B	223.82M	0.33%
Dec 31, 2023	67.16B	-6.24B	-8.51%
Dec 31, 2022	73.40B	7.61B	11.56%
Dec 31, 2021	65.79B	15.27B	30.22%
Dec 31, 2020	50.53B	7.89B	18.49%